Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy

Authors :: Markian Bochan
Reese A. Cosimi
Amy T Chang
Source :: Open Forum Infectious Diseases
Publication Year :: 2020
Publisher :: Oxford University Press (OUP), 2020.
Abstract: This is a single-center retrospective observational cohort study comparing daptomycin/ceftaroline combination therapy with rifampin-adjunct therapy for the treatment of staphylococcal device infections. The results of this study support use of the daptomycin/ceftaroline as an alternative or salvage option to standard of care.

Full Text Access

Tools